Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

The Global Wicked Problem of Corruption and Its Risks for Access to HIV/AIDS Medicines.

Kohler JC, Chang Pico T, Vian T, Mackey TK.

Clin Pharmacol Ther. 2018 Dec;104(6):1054-1056. doi: 10.1002/cpt.1172. Epub 2018 Aug 3.

PMID:
30076604
2.

Combating corruption in the pharmaceutical arena.

Lexchin J, Kohler JC, Gagnon MA, Crombie J, Thacker P, Shnier A.

Indian J Med Ethics. 2018 Jul-Sep;3(3):234-239. doi: 10.20529/IJME.2018.022. Epub 2018 Mar 15.

4.

Corporate social responsibility to improve access to medicines: the case of Brazil.

Thorsteinsdóttir H, Ovtcharenko N, Kohler JC.

Global Health. 2017 Feb 21;13(1):10. doi: 10.1186/s12992-017-0235-7.

5.
6.

The disease of corruption: views on how to fight corruption to advance 21st century global health goals.

Mackey TK, Kohler JC, Savedoff WD, Vogl F, Lewis M, Sale J, Michaud J, Vian T.

BMC Med. 2016 Sep 29;14(1):149.

7.

Does Pharmaceutical Pricing Transparency Matter? Examining Brazil's Public Procurement System.

Kohler JC, Mitsakakis N, Saadat F, Byng D, Martinez MG.

Global Health. 2015 Aug 4;11:34. doi: 10.1186/s12992-015-0118-8.

8.

Participatory health councils and good governance: healthy democracy in Brazil?

Kohler JC, Martinez MG.

Int J Equity Health. 2015 Feb 19;14:21. doi: 10.1186/s12939-015-0151-5.

9.

Why the MDGs need good governance in pharmaceutical systems to promote global health.

Kohler JC, Mackey TK, Ovtcharenko N.

BMC Public Health. 2014 Jan 21;14:63. doi: 10.1186/1471-2458-14-63.

10.

"To patent or not to patent? the case of Novartis' cancer drug Glivec in India".

Gabble R, Kohler JC.

Global Health. 2014 Jan 6;10:3. doi: 10.1186/1744-8603-10-3.

11.

Canada's neglected tropical disease research network: who's in the core-who's on the periphery?

Phillips K, Kohler JC, Pennefather P, Thorsteinsdottir H, Wong J.

PLoS Negl Trop Dis. 2013 Dec 5;7(12):e2568. doi: 10.1371/journal.pntd.0002568. eCollection 2013.

12.

Prescribing gabapentin off label: Perspectives from psychiatry, pain and neurology specialists.

Fukada C, Kohler JC, Boon H, Austin Z, Krahn M.

Can Pharm J (Ott). 2012 Nov;145(6):280-284.e1. doi: 10.3821/145.6.cpj280.

13.

An examination of pharmaceutical systems in severely disrupted countries.

Kohler JC, Pavignani E, Michael M, Ovtcharenko N, Murru M, Hill PS.

BMC Int Health Hum Rights. 2012 Dec 6;12:34. doi: 10.1186/1472-698X-12-34.

14.

The use of cost-effectiveness analysis for pediatric immunization in developing countries.

Gauvreau CL, Ungar WJ, Köhler JC, Zlotkin S.

Milbank Q. 2012 Dec;90(4):762-90. doi: 10.1111/j.1468-0009.2012.00682.x.

15.

How to achieve international action on falsified and substandard medicines.

Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M.

BMJ. 2012 Nov 13;345:e7381. doi: 10.1136/bmj.e7381. No abstract available.

16.

The make or buy debate: considering the limitations of domestic production in Tanzania.

Wilson KR, Kohler JC, Ovtcharenko N.

Global Health. 2012 Jun 29;8:20. doi: 10.1186/1744-8603-8-20.

18.

The danger of imperfect regulation: OxyContin use in the United States and Canada.

Lexchin J, Kohler JC.

Int J Risk Saf Med. 2011;23(4):233-40. doi: 10.3233/JRS-2011-0539.

PMID:
22156088
19.

Canada's Access to Medicines Regime: Promise or Failure of Humanitarian Effort?

Kohler JC, Lexchin J, Kuek V, Orbinski J.

Healthc Policy. 2010 Feb;5(3):40-8.

20.

Panel: Canada's law on global access to affordable medicines.

Avafia T, Morrison C, Clark B, Kohler JC.

HIV AIDS Policy Law Rev. 2009 Dec;14(2):76-83.

PMID:
20225526
21.

Achieving a dream: meeting policy goals related to improving drug access.

Zakus D, Kohler JC, Zakriova V, Yarmoshuk A.

Open AIDS J. 2010 Jan 19;4:25-7. doi: 10.2174/1874613601004020025.

22.

Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime.

Esmail LC, Phillips K, Kuek V, Cosio AP, Kohler JC.

BMC Int Health Hum Rights. 2010 Jan 4;10:1. doi: 10.1186/1472-698X-10-1.

23.

The role of supportive supervision on immunization program outcome - a randomized field trial from Georgia.

Djibuti M, Gotsadze G, Zoidze A, Mataradze G, Esmail LC, Kohler JC.

BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S11. doi: 10.1186/1472-698X-9-S1-S11.

24.

Supplemental Content

Loading ...
Support Center